论文部分内容阅读
本文报告应用上海生化试剂三厂合成的苯酪肽行胰腺外分泌功能试验(简称BT-PABA试验)及同时内服生鸡蛋清的抑制试验(简称BT-PABA抑制试验)。对无消化系统疾病的健康人42名,与不同胰腺疾病18例,胆道疾病8例,失代偿期肝硬化及尿毒症各2例,观察对胰腺疾病的诊断价值。
This article reports the application of the Shanghai Biochemical Reagent Factory synthesis of phenylchromycin pancreas exocrine function test (referred to as BT-PABA test) and simultaneous oral administration of egg white inhibition test (referred to as BT-PABA inhibition test). Forty-two healthy people without digestive system diseases, 18 cases with different pancreatic diseases, 8 cases with biliary diseases, 2 cases with decompensated cirrhosis and uremia, and the diagnostic value of pancreatic diseases were observed.